tradingkey.logo
tradingkey.logo
Search

Keros Therapeutics Inc

KROS
Add to Watchlist
10.070USD
-0.150-1.47%
Close 07-31 16:00ETQuotes delayed by 15 min
199.30MMarket Cap
LossP/E TTM

KROS Financials

See Keros Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Keros Therapeutics Inc Earnings Date

Latest Release
May 14, 2026
EPS / Forecast
-1.21/-1.02
Revenue / Forecast
367.00K/583.33K
Period
FY2025 Earnings
Revenue(YoY)
244.06M
6774.96%
EPS(YoY)
2.34
146.71%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-133.00%-1.21
24.06%-0.87
87.28%-0.18
39.71%-0.76
402.94%3.66
14.61%-1.14
-5.97%-1.41
1.06%-1.25
4.27%-1.21
-22.90%-1.34
---1.33
---1.27
---1.26
---1.09
----
----
----
----
----
----
Revenue
-99.83%367.00K
-87.34%385.00K
3575.77%14.26M
49002.70%18.17M
254413.25%211.25M
2027.27%3.04M
4750.00%388.00K
--37.00K
--83.00K
--143.00K
--8.00K
----
----
-100.00%0.00
--0.00
-100.00%0.00
----
--20.00M
--0.00
--100.00K
Net Profit
-115.97%-23.71M
49.03%-23.46M
86.25%-7.28M
32.17%-30.70M
444.32%148.45M
-14.37%-46.03M
-34.27%-52.96M
-20.67%-45.26M
-20.42%-43.11M
-35.42%-40.24M
-67.77%-39.44M
-37.55%-37.51M
-48.04%-35.80M
-328.21%-29.72M
-15.82%-23.51M
-74.54%-27.27M
-52.26%-24.19M
28.19%-6.94M
-68.64%-20.30M
-42.50%-15.62M
Net Margin
-9292.51%-6459.95%
-302.76%-6093.77%
99.63%-51.04%
99.86%-168.96%
100.14%70.27%
94.62%-1513.02%
97.23%-13648.45%
---122316.22%
---51944.58%
---28141.96%
---493000.00%
----
----
----
----
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
----
----
Revenue
-99.83%367.00K
-87.34%385.00K
3575.77%14.26M
49002.70%18.17M
254413.25%211.25M
2027.27%3.04M
4750.00%388.00K
--37.00K
--83.00K
--143.00K
--8.00K
----
----
-100.00%0.00
--0.00
-100.00%0.00
----
--20.00M
--0.00
--100.00K
Operating profit
-117.02%-25.88M
45.04%-29.27M
73.77%-15.38M
21.06%-39.82M
413.59%152.04M
-14.64%-53.25M
-35.53%-58.66M
-22.02%-50.44M
-24.73%-48.48M
-45.35%-46.45M
-54.70%-43.28M
-34.53%-41.34M
-61.11%-38.87M
-556.80%-31.96M
-38.52%-27.98M
-97.72%-30.73M
-53.00%-24.13M
63.39%-4.87M
-69.04%-20.20M
-42.40%-15.54M
Net Profit
-115.97%-23.71M
49.03%-23.46M
86.25%-7.28M
32.17%-30.70M
444.32%148.45M
-14.37%-46.03M
-34.27%-52.96M
-20.67%-45.26M
-20.42%-43.11M
-35.42%-40.24M
-67.77%-39.44M
-37.55%-37.51M
-48.04%-35.80M
-328.21%-29.72M
-15.82%-23.51M
-74.54%-27.27M
-52.26%-24.19M
28.19%-6.94M
-68.64%-20.30M
-42.50%-15.62M
Current assets
-61.73%290.68M
-46.44%315.43M
30.30%719.31M
69.35%732.81M
64.00%759.51M
69.57%588.89M
81.33%552.05M
29.44%432.71M
27.86%463.13M
21.53%347.29M
23.82%304.44M
50.35%334.31M
56.66%362.22M
13.65%285.77M
8.76%245.88M
-7.90%222.36M
-9.67%231.22M
-6.08%251.44M
65.72%226.07M
62.55%241.42M
Total current liabilities
-67.36%12.85M
-25.63%20.41M
-16.94%24.09M
63.37%34.71M
110.38%39.38M
12.62%27.45M
73.68%29.01M
32.00%21.25M
21.09%18.72M
47.30%24.37M
44.91%16.70M
4.15%16.09M
32.71%15.46M
39.68%16.55M
4.63%11.53M
105.19%15.45M
30.15%11.65M
64.89%11.85M
61.39%11.02M
-9.20%7.53M
Total assets
-60.20%312.29M
-45.12%338.02M
28.23%742.78M
66.40%757.16M
61.49%784.56M
66.44%615.89M
77.56%579.27M
27.71%455.02M
26.37%485.82M
20.62%370.02M
29.18%326.25M
57.20%356.31M
63.49%384.44M
20.19%306.78M
9.82%252.55M
-6.90%226.66M
-8.76%235.14M
-5.27%255.25M
66.34%229.96M
61.83%243.46M
Total liabilities
-52.12%26.66M
-21.30%34.89M
-15.58%39.20M
47.87%50.43M
74.73%55.69M
17.25%44.33M
52.72%46.44M
13.51%34.11M
8.22%31.87M
28.80%37.81M
163.82%30.41M
94.43%30.05M
152.85%29.45M
143.09%29.36M
0.36%11.53M
97.99%15.45M
24.47%11.65M
56.40%12.08M
53.37%11.48M
-14.01%7.80M
Total equity
-60.81%285.63M
-46.96%303.13M
32.04%703.58M
67.90%706.73M
60.56%728.87M
72.04%571.55M
80.11%532.84M
29.01%420.92M
27.88%453.95M
19.75%332.21M
22.74%295.84M
54.47%326.26M
58.83%354.98M
14.08%277.42M
10.32%241.03M
-10.37%211.21M
-10.02%223.49M
-7.09%243.17M
67.09%218.48M
66.71%235.66M
Net operating income
-102.19%-3.53M
40.68%-27.29M
110.65%3.25M
25.57%-29.62M
461.69%161.17M
-80.71%-46.01M
10.25%-30.50M
-29.09%-39.80M
-30.16%-44.56M
-18.73%-25.46M
-38.13%-33.98M
-36.49%-30.83M
-2299.09%-34.23M
-9.60%-21.44M
-70.36%-24.60M
-28.08%-22.59M
86.42%-1.43M
-144.84%-19.57M
-33.02%-14.44M
-77.67%-17.64M
Net investment
87.08%-73.00K
53.63%-134.00K
65.80%-132.00K
-132.26%-720.00K
40.27%-565.00K
46.58%-289.00K
29.82%-386.00K
0.32%-310.00K
10.92%-946.00K
-54.13%-541.00K
-212.50%-550.00K
45.15%-311.00K
-622.45%-1.06M
-120.75%-351.00K
-21.38%-176.00K
-11.18%-567.00K
30.00%-147.00K
-165.00%-159.00K
-383.33%-145.00K
-1721.43%-510.00K
Net financing
-58000.00%-2.32M
-601.21%-378.63M
-99.91%140.00K
-99.52%17.00K
-100.00%4.00K
9.08%75.54M
54809.86%155.94M
102.93%3.53M
45.62%156.80M
12.76%69.25M
-99.42%284.00K
-82.93%1.74M
91152.54%107.68M
116.13%61.42M
138708.57%48.58M
17780.70%10.19M
180.95%118.00K
-79.72%28.42M
288.89%35.00K
-99.94%57.00K

FAQs

What is the total revenue of Keros Therapeutics Inc?

According to Keros Therapeutics Inc's FY2025 earnings report, its total revenue reached 244.06M, with a year-on-year change of 3.55M.

What are the current assets of Keros Therapeutics Inc?

According to Keros Therapeutics Inc's FY2025 earnings report, its current assets were 315.43M, with a year-on-year change of -46.44.

What are the total assets of Keros Therapeutics Inc?

According to Keros Therapeutics Inc's FY2025 earnings report, its total assets of Keros Therapeutics Inc were 338.02M, with a year-on-year change of -45.12.

What are the total liabilities of Keros Therapeutics Inc?

According to Keros Therapeutics Inc's FY2025 earnings report, its total liabilities of Keros Therapeutics Inc were 34.89M, with a year-on-year change of -21.30.

What is the total equity of Keros Therapeutics Inc?

According to Keros Therapeutics Inc's FY2025 earnings report, its total equity of Keros Therapeutics Inc was 303.13M, with a year-on-year change of -46.96.

What is the net operating income of Keros Therapeutics Inc?

According to Keros Therapeutics Inc's FY2025 earnings report, its net operating income of Keros Therapeutics Inc was 70.67M, with a year-on-year change of 133.52.

What is the net investment of Keros Therapeutics Inc?

According to Keros Therapeutics Inc's FY2025 earnings report, its net investment of Keros Therapeutics Inc was -1.55M, with a year-on-year change of 19.68.

What is the net financing of Keros Therapeutics Inc?

According to Keros Therapeutics Inc's FY2025 earnings report, its net financing of Keros Therapeutics Inc was -378.47M, with a year-on-year change of -196.59.

What is the Earnings Per Share (EPS) of Keros Therapeutics Inc?

According to Keros Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 2.34, with a year-on-year change of 146.71.

What is the net income of Keros Therapeutics Inc?

According to Keros Therapeutics Inc's FY2025 earnings report, its net income was 87.01M, with a year-on-year change of 146.44.

What is the net margin of Keros Therapeutics Inc?

According to Keros Therapeutics Inc's FY2025 earnings report, its net profit margin was 35.65, with a year-on-year change of 100.68.

What is the Return on Equity (ROE) of Keros Therapeutics Inc?

According to Keros Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was 19.90, with a year-on-year change of 147.99.

What is the Return on Assets (ROA) of Keros Therapeutics Inc?

According to Keros Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was 18.24, with a year-on-year change of 148.00.

What is the operating profit of Keros Therapeutics Inc?

According to Keros Therapeutics Inc's FY2025 earnings report, its operating profit was 70.67M, with a year-on-year change of 133.52.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.